The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-methylphenyl)-1-methyl-4-(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl)piperazine ID: ALA3818673
PubChem CID: 59485037
Max Phase: Preclinical
Molecular Formula: C24H32N2O
Molecular Weight: 364.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(N2CCN(c3c(C)c(C)c4c(c3C)CC(C)(C)O4)CC2)cc1
Standard InChI: InChI=1S/C24H32N2O/c1-16-7-9-20(10-8-16)25-11-13-26(14-12-25)22-17(2)18(3)23-21(19(22)4)15-24(5,6)27-23/h7-10H,11-15H2,1-6H3
Standard InChI Key: RYIBYVIRLMVBSK-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
1.7138 -1.2033 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9991 2.7132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3560 -1.3452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9991 -2.7132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1658 1.0705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1810 -1.0255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6168 1.4950 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9144 0.7421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2151 1.4892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2185 2.9892 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9211 3.7421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6204 2.9950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5198 3.7366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8185 2.9858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.1180 3.7350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.1190 5.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8204 5.9858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5209 5.2367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.1586 5.8343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 1 1 0
1 2 1 0
2 3 1 0
3 5 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
6 10 1 0
8 11 1 0
9 12 1 0
2 13 1 0
2 14 1 0
7 15 1 0
15 16 1 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
18 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
24 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.53Molecular Weight (Monoisotopic): 364.2515AlogP: 4.96#Rotatable Bonds: 2Polar Surface Area: 15.71Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.69CX LogP: 6.45CX LogD: 6.45Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.75Np Likeness Score: -0.36
References 1. Wakabayashi T, Tokunaga N, Tokumaru K, Ohra T, Koyama N, Hayashi S, Yamada R, Shirasaki M, Inui Y, Tsukamoto T.. (2016) Discovery of Benzofuran Derivatives that Collaborate with Insulin-Like Growth Factor 1 (IGF-1) to Promote Neuroprotection., 59 (10): [PMID:27163512 ] [10.1021/acs.jmedchem.6b00191 ]